The Nigeria Center for Disease Control, NCDC, has responded to the British government declaration of a low cost and generally available vaccine that saves complicated patients of COVID-19.

Remember that, British Prime Minister on Tuesday said UK researchers established a fresh vaccine, which is working fast and has declined COVID-19 deaths risk.

The vaccine known as Dexamethasone has declined death risk for patients in ventilators by one-third and oxygen by one fifth.

NCDC responded on its verified official Twitter page, disclosed that the vaccine will not be used to treat patients because it is yet to be approved by the World Health Organization, WHO.

NCDC tweeted said, “The NCDC is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.

“The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.

“Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19.

“In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by @WHO.”

Post a Comment

Previous Post Next Post